Reanalysis and reclassification of rare genetic variants associated with inherited arrhythmogenic syndromes
dc.contributor.author
dc.date.accessioned
2021-05-12T09:54:38Z
dc.date.available
2021-05-12T09:54:38Z
dc.date.issued
2020-04-05
dc.identifier.uri
dc.description.abstract
Background: Accurate interpretation of rare genetic variants is a challenge for clinical translation. Updates in recommendations for rare variant classification require the reanalysis and reclassification. We aim to perform an exhaustive re-analysis of rare variants associated with inherited arrhythmogenic syndromes, which were classified ten years ago, to determine whether their classification aligns with current standards and research findings.
Methods: In 2010, the rare variants identified through genetic analysis were classified following recommendations available at that time. Nowadays, the same variants have been reclassified following current American College of Medical Genetics and Genomics recommendations.
Findings: Our cohort included 104 cases diagnosed with inherited arrhythmogenic syndromes and 17 post-mortem cases in which inherited arrhythmogenic syndromes was cause of death. 71.87% of variants change their classification. While 65.62% of variants were classified as likely pathogenic in 2010, after reanalysis, only 17.96% remain as likely pathogenic. In 2010, 18.75% of variants were classified as uncertain role but nowadays 60.15% of variants are classified of unknown significance.
Interpretation: Reclassification occurred in more than 70% of rare variants associated with inherited arrhythmogenic syndromes. Our results support the periodical reclassification and personalized clinical translation of rare variants to improve diagnosis and adjust treatment
dc.description.sponsorship
This work was supported by Obra Social "La Caixa Foundation" (ID
100010434, LCF/PR/GN16/50290001 and LCF/PR/GN19/50320002),
Fondo Investigacion Sanitaria (FIS PI16/01203 and FIS, PI17/01690)
from Instituto Salud Carlos III (ISCIII), Sociedad Espanola de Cardiolo- ~
gía (Proyecto Investigacion B asica Cardiología 2015 de los Socios
Estrategicos SEC), and “Fundacio Privada Daniel Bravo Andreu”.
CIBERCV is an initiative of the ISCIII, Spanish Ministry of Economy
and Competitiveness
dc.format.mimetype
application/pdf
dc.language.iso
eng
dc.publisher
Elsevier
dc.relation.isformatof
Reproducció digital del document publicat a: https://doi.org/10.1016/j.ebiom.2020.102732
dc.relation.ispartof
EBioMedicine, 2020, vol. 54, art.núm. 102732
dc.relation.ispartofseries
Articles publicats (D-CM)
dc.rights
Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.uri
dc.subject
dc.title
Reanalysis and reclassification of rare genetic variants associated with inherited arrhythmogenic syndromes
dc.type
info:eu-repo/semantics/article
dc.rights.accessRights
info:eu-repo/semantics/openAccess
dc.type.version
info:eu-repo/semantics/publishedVersion
dc.identifier.doi
dc.identifier.idgrec
031572
dc.type.peerreviewed
peer-reviewed
dc.identifier.eissn
2352-3964